Responses
Poster Presentations
Rheumatoid arthritis - prognosis, predictors and outcome
FRI0046 Methotrexate Dose Reduction During DAS28 Remission was a Significant Factor Associated with Early Deterioration in Patients with Rheumatoid Arthritis from the Iorra Cohort
Compose a Response to This Article
Other responses
No responses have been published for this article.